MEDISCA News at Your Fingertips

Earlier this year MEDISCA announced that in June it would match up to $100,000 in donations to the Alliance for Pharmacy Compounding (APC) Media Fund Campaign, encouraging investments to support APC’s nationwide marketing and lobbying effort to secure compounded hormone therapy. The result was astonishing, bringing in $113,545 in investments from compounding pharmacies, which, with Medisca’s match, elevated the final amount raised in June to $213,545.

MEDISCA has finalized an exclusive distribution agreement with pharmaceutical manufacturer Sichuan Deebio Pharmaceutical Co.,Ltd to provide thyroid active pharmaceutical ingredient (API) to the compounding and non-compounding industries in the United States. This agreement will bring much-needed stability to a market that has seen inconsistent supply for several years.

MEDISCA Pledges $100,000 to Alliance for Pharmacy Compounding (APC) National Media Campaign to Help Protect Compounded Hormone Therapy Medications.

On March 19, 2021, future pharmacists from over 35 colleges came together to participate in a live FREE Virtual Student Event sponsored by Medisca, a global leader in the compounding pharmaceutical industry. The event, created and hosted by LP3 Network, attracted over 350 students from more than 10 countries and sought to promote the industry through interactive discussions and first-hand narratives about the vital role that compounding pharmacies played during the COVID-19 pandemic.

Medisca removes potential allergens from topical products and provides essential BUD testing to support clients.

Medisca Announces Further Measures Reinforcing Its Commitment to a Transparent and Compliant Pharmaceutical Drug Supply Chain